These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 29073812)

  • 1. Urinary neutrophil gelatinase-associated lipocalin and monocyte chemoattractant protein 1 as biomarkers for lupus nephritis in Colombian SLE patients.
    Gómez-Puerta JA; Ortiz-Reyes B; Urrego T; Vanegas-García AL; Muñoz CH; González LA; Cervera R; Vásquez G
    Lupus; 2018 Apr; 27(4):637-646. PubMed ID: 29073812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary levels of ceruloplasmin and monocyte chemoattractant protein-1 correlate with extra-capillary proliferation and chronic damage in patients with lupus nephritis.
    Urrego-Callejas T; Álvarez SS; Arias LF; Reyes BO; Vanegas-García AL; González LA; Muñoz-Vahos CH; Vásquez G; Quintana LF; Gómez-Puerta JA
    Clin Rheumatol; 2021 May; 40(5):1853-1859. PubMed ID: 33079302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis.
    Urrego T; Ortiz-Reyes B; Vanegas-García AL; Muñoz CH; González LA; Vásquez G; Gómez-Puerta JA
    Reumatol Clin (Engl Ed); 2020; 16(1):17-23. PubMed ID: 29530762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum and urine TNF-like weak inducer of apoptosis, monocyte chemoattractant protein-1 and neutrophil gelatinase-associated lipocalin as biomarkers of disease activity in patients with systemic lupus erythematosus.
    Mirioglu S; Cinar S; Yazici H; Ozluk Y; Kilicaslan I; Gul A; Ocal L; Inanc M; Artim-Esen B
    Lupus; 2020 Apr; 29(4):379-388. PubMed ID: 32041504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus.
    Brunner HI; Mueller M; Rutherford C; Passo MH; Witte D; Grom A; Mishra J; Devarajan P
    Arthritis Rheum; 2006 Aug; 54(8):2577-84. PubMed ID: 16868980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Composite urinary biomarkers to predict pathological tubulointerstitial lesions in lupus nephritis.
    Ding Y; Nie LM; Pang Y; Wu WJ; Tan Y; Yu F; Zhao MH
    Lupus; 2018 Oct; 27(11):1778-1789. PubMed ID: 30020021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary neutrophil gelatinase-associated lipocalin as a marker for disease activity in lupus nephritis.
    El Shahawy MS; Hemida MH; Abdel-Hafez HA; El-Baz TZ; Lotfy AM; Emran TM
    Scand J Clin Lab Invest; 2018 Jul; 78(4):264-268. PubMed ID: 29533691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International validation of a urinary biomarker panel for identification of active lupus nephritis in children.
    Smith EM; Jorgensen AL; Midgley A; Oni L; Goilav B; Putterman C; Wahezi D; Rubinstein T; Ekdawy D; Corkhill R; Jones CA; Marks SD; Newland P; Pilkington C; Tullus K; Beresford MW
    Pediatr Nephrol; 2017 Feb; 32(2):283-295. PubMed ID: 27590021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
    Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
    Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4.
    Julkunen H; Ekblom-Kullberg S; Miettinen A
    Rheumatol Int; 2012 Aug; 32(8):2445-51. PubMed ID: 21706294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis.
    Mok CC; Soliman S; Ho LY; Mohamed FA; Mohamed FI; Mohan C
    Arthritis Res Ther; 2018 Jan; 20(1):6. PubMed ID: 29325582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine neutrophil gelatinase-associated lipocalin to predict renal response after induction therapy in active lupus nephritis.
    Satirapoj B; Kitiyakara C; Leelahavanichkul A; Avihingsanon Y; Supasyndh O
    BMC Nephrol; 2017 Aug; 18(1):263. PubMed ID: 28778196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of neutrophil gelatinase-associated lipocalin and other laboratory markers for lupus nephritis: a cross-sectional investigation.
    La'ulu SL; Suh-Lailam BB; Davis KW; Straseski JA; Tebo AE
    Ann Clin Biochem; 2017 Mar; 54(2):240-245. PubMed ID: 27166308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary lipocalin-2 is associated with renal disease activity in human lupus nephritis.
    Pitashny M; Schwartz N; Qing X; Hojaili B; Aranow C; Mackay M; Putterman C
    Arthritis Rheum; 2007 Jun; 56(6):1894-903. PubMed ID: 17530720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil gelatinase-associated lipocalin as a biomarker for lupus nephritis.
    Torres-Salido MT; Cortés-Hernández J; Vidal X; Pedrosa A; Vilardell-Tarrés M; Ordi-Ros J
    Nephrol Dial Transplant; 2014 Sep; 29(9):1740-9. PubMed ID: 24711435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity.
    Hinze CH; Suzuki M; Klein-Gitelman M; Passo MH; Olson J; Singer NG; Haines KA; Onel K; O'Neil K; Silverman ED; Tucker L; Ying J; Devarajan P; Brunner HI
    Arthritis Rheum; 2009 Sep; 60(9):2772-81. PubMed ID: 19714584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of age and gender on reference levels of biomarkers comprising the pediatric Renal Activity Index for Lupus Nephritis (p-RAIL).
    Bennett MR; Ma Q; Ying J; Devarajan P; Brunner H
    Pediatr Rheumatol Online J; 2017 Oct; 15(1):74. PubMed ID: 29029629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary CXCL-10/IP-10 and MCP-1 as markers to assess activity of lupus nephritis.
    Abujam B; Cheekatla S; Aggarwal A
    Lupus; 2013 May; 22(6):614-23. PubMed ID: 23629827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus.
    Zivković V; Stanković A; Cvetković T; Mitić B; Kostić S; Nedović J; Stamenković B
    Srp Arh Celok Lek; 2014; 142(7-8):431-6. PubMed ID: 25233687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary neutrophil gelatinase-associated lipocalin is a potential biomarker for renal damage in patients with systemic lupus erythematosus.
    Yang CC; Hsieh SC; Li KJ; Wu CH; Lu MC; Tsai CY; Yu CL
    J Biomed Biotechnol; 2012; 2012():759313. PubMed ID: 22500106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.